NLS Financial Statements From 2010 to 2024

NLSPW Stock  USD 0.01  0  18.18%   
NLS Pharmaceutics financial statements provide useful quarterly and yearly information to potential NLS Pharmaceutics AG investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on NLS Pharmaceutics financial statements helps investors assess NLS Pharmaceutics' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting NLS Pharmaceutics' valuation are summarized below:
Market Capitalization
37.8 M
There are over one hundred eighteen available fundamental ratios for NLS Pharmaceutics, which can be analyzed over time and compared to other ratios. All traders should should check NLS Pharmaceutics' last-minute fundamental trends against the trends from 2010 to 2024 to make sure the company is sustainable. Market Cap is likely to climb to about 1.1 B in 2024. Enterprise Value is likely to climb to about 1.1 B in 2024
Check NLS Pharmaceutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NLS Pharmaceutics' main balance sheet or income statement drivers, such as Interest Income of 681.3 K, Depreciation And Amortization of 9.8 K or Interest Expense of 137.9 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NLS financial statements analysis is a perfect complement when working with NLS Pharmaceutics Valuation or Volatility modules.
  
Check out the analysis of NLS Pharmaceutics Correlation against competitors.

NLS Pharmaceutics Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.3 M1.8 M2.7 M
Slightly volatile
Short and Long Term Debt Total1.4 M1.5 M5.8 M
Slightly volatile
Other Current LiabilitiesM1.7 M705 K
Slightly volatile
Total Current Liabilities4.5 M7.9 M2.6 M
Slightly volatile
Accounts Payable2.7 M4.6 M1.6 M
Slightly volatile
Cash852.8 K897.7 K2.3 M
Pretty Stable
Non Current Assets Total22.4 K23.6 K107.9 K
Pretty Stable
Non Currrent Assets Other16 K16.9 K91.9 K
Pretty Stable
Long Term Debt268 K282.1 K5.3 M
Slightly volatile
Cash And Short Term Investments852.8 K897.7 K2.3 M
Pretty Stable
Common Stock Shares Outstanding40.1 M38.2 M15.6 M
Slightly volatile
Liabilities And Stockholders Equity3.3 M1.8 M2.7 M
Slightly volatile
Non Current Liabilities Total3.4 M2.8 M6.4 M
Slightly volatile
Capital Surpluse17.1 M23.7 M13.6 M
Slightly volatile
Other Current Assets971.7 K925.4 K219.4 K
Slightly volatile
Other Stockholder Equity35.5 M61 M21.4 M
Slightly volatile
Total Liabilities6.6 M10.7 MM
Slightly volatile
Total Current Assets3.1 M1.8 M2.6 M
Pretty Stable
Common Stock770.1 K733.4 K264.5 K
Slightly volatile
Net Receivables10.1 K10.7 K21.4 K
Slightly volatile
Short and Long Term Debt1.3 M1.9 MM
Slightly volatile
Capital Stock397.9 K733.4 K242.4 K
Slightly volatile
Short Term Debt1.8 M1.9 M167.6 M
Pretty Stable
Other Assets0.860.9173.5 K
Slightly volatile

NLS Pharmaceutics Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income681.3 K505.9 K796.7 K
Slightly volatile
Interest Expense137.9 K145.2 K646.5 K
Slightly volatile
Selling General Administrative6.2 M5.9 M1.9 M
Slightly volatile
Other Operating Expenses8.6 M11.8 M6.9 M
Slightly volatile
Research Development4.5 M5.9 M4.2 M
Pretty Stable
Total Operating Expenses8.6 M11.8 M6.9 M
Slightly volatile
Selling And Marketing Expenses10.8 K11.4 K2.6 M
Very volatile
Cost Of Revenue12.1 K13.1 K10.5 K
Slightly volatile

NLS Pharmaceutics Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Sale Purchase Of Stock2.6 M2.9 M3.2 M
Slightly volatile
Begin Period Cash Flow9.4 M8.9 M2.2 M
Slightly volatile
Total Cash From Financing Activities1.6 M1.6 M6.4 M
Very volatile
End Period Cash Flow852.8 K897.7 K2.3 M
Pretty Stable
Depreciation9.8 K10.3 K52.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Average Payables1.6 M1.8 M1.4 M
Slightly volatile
Capex To Depreciation4.0E-44.0E-43.1491
Slightly volatile
Payables Turnover0.00480.00250.0054
Slightly volatile
Cash Per Share0.02230.02350.1594
Pretty Stable
Days Payables Outstanding76.6 K148.3 K70.5 K
Slightly volatile
Income Quality0.520.79560.7171
Pretty Stable
Current Ratio0.220.23021.6079
Slightly volatile
Graham Number1.221.28842.5575
Slightly volatile
Average Receivables29.8 K50.5 K31.4 K
Slightly volatile
Interest Debt Per Share0.04430.04660.5367
Slightly volatile
Debt To Assets0.971.025.7598
Very volatile
Days Of Payables Outstanding76.6 K148.3 K70.5 K
Slightly volatile
Ebt Per Ebit1.31.03091.1782
Very volatile
Quick Ratio0.220.23021.6106
Slightly volatile
Cash Ratio0.110.11331.5238
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.80.90.9823
Slightly volatile
Debt Ratio0.971.025.7598
Very volatile

NLS Pharmaceutics Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.1 B897.9 M1.2 B
Slightly volatile
Enterprise Value1.1 B898.6 M1.2 B
Slightly volatile

NLS Fundamental Market Drivers

Cash And Short Term Investments897.7 K

About NLS Pharmaceutics Financial Statements

NLS Pharmaceutics investors use historical fundamental indicators, such as NLS Pharmaceutics' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NLS Pharmaceutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue2.9 B1.8 B
Cost Of Revenue13.1 K12.1 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NLS Stock Analysis

When running NLS Pharmaceutics' price analysis, check to measure NLS Pharmaceutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NLS Pharmaceutics is operating at the current time. Most of NLS Pharmaceutics' value examination focuses on studying past and present price action to predict the probability of NLS Pharmaceutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NLS Pharmaceutics' price. Additionally, you may evaluate how the addition of NLS Pharmaceutics to your portfolios can decrease your overall portfolio volatility.